Irsogladine maleate is a mucosal protective drug used mainly to treat gastric ulcers and acute gastritis, particularly to accelerate healing after Helicobacter pylori eradication. It functions as a phosphodiesterase (PDE) inhibitor to protect the gastric lining and is also used to prevent and treat chemotherapy-induced oral mucositis. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Dicloguamine maleate. Its PubChem CID is 22719248.
Irsogladine Maleate
| CAS No | 84504-69-8 |
|---|---|
| Molecular Formula | C13H11Cl2N5O4 |
| Molecular Weight | 372.16 g/mol |
| Synonyms | (E)-but-2-enedioic acid;6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Irsogladine maleate is a mucosal protective drug used mainly to treat gastric ulcers and acute gastritis, particularly to accelerate healing after Helicobacter pylori eradication.
The listed CAS number is 84504-69-8.
The listed molecular formula is C13H11Cl2N5O4.
The listed molecular weight is 372.16 g/mol.
(E)-but-2-enedioic acid;6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine.
The source lists Dicloguamine maleate.